TWP
FOLD

Tempus Wealth Planning’s Amicus Therapeutics FOLD Stock Holding History

Tempus Wealth Planning’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-53,132
Closed -$304K – 281
2025
Q2 		$304K Buy
53,132
+23,619
+80% +$152K 0.08% 210
2025
Q1 		$241K Buy
29,513
+1,990
+7% +$18.4K 0.07% 224
2024
Q4 		$259K Buy
+27,523
New +$286K 0.08% 208

Other funds holding FOLD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Tempus Wealth Planning's FOLD Position: Q3 2025 in Review

Tempus Wealth Planning sold out of Amicus Therapeutics (FOLD) in Q3 2025, closing a stake of 53,132 shares — an estimated $304K sold.

Tempus Wealth Planning first reported a position in FOLD in Q4 2024 and held it in 3 quarters. The position peaked at $304K in Q2 2025. 287 funds tracked by Wall St. Rank hold FOLD as of Q3 2025.

  • Tempus Wealth Planning reported no remaining Amicus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Tempus Wealth Planning sold 53,132 Amicus Therapeutics shares in Q3 2025, an estimated $304K.
  • Tempus Wealth Planning first reported a position in Amicus Therapeutics in Q4 2024 and held it in 3 quarters.
  • Tempus Wealth Planning's Amicus Therapeutics position peaked at $304K in Q2 2025.
  • 287 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2025.

Based on Tempus Wealth Planning's 13F filing for Q3 2025, filed 6 Nov 2025.